Literature DB >> 33880335

Neutrophil-to-lymphocyte ratio as a predictive marker for severe pediatric sepsis.

Xi Zhong1, Aijia Ma1, Zhongwei Zhang1, Yong Liu2, Guopeng Liang1.   

Abstract

BACKGROUND: Although neutrophil-to-lymphocyte ratio (NLR) has been extensively studied in several diseases, its role in pediatric sepsis remains unclear. Our study aimed to assess the predictive significance of NLR for severe pediatric sepsis in the pediatric intensive care unit (PICU).
METHODS: We retrospectively recruited critically ill children in the PICU with severe pediatric sepsis from January 2019 to January 2020 in West China Hospital of Sichuan University. Univariate and multivariable logistic regression analysis was used to assess the risk factors of severe pediatric sepsis. Receiver operating characteristic (ROC) curves were plotted for the comparison of the prediction significance of NLR.
RESULTS: Overall, 202 patients (severe sepsis 45; non-severe sepsis 157) were included. In the severe sepsis group, the levels of NLR (P<0.001), procalcitonin (PCT; P<0.001), and the Pediatric Risk of Mortality score (PRISM III) were higher than those in the nonsevere sepsis group (P<0.001). The PICU stay time (P<0.001), mechanical ventilation length (P=0.004), and hospital stay time (P<0.001) in the severe sepsis patients were noticeably more extended than those in the control patients. The area under the ROC curve (AUC) of NLR was 0.715 (P<0.001), which was higher than that of the PRISM III score (AUC =0.651, P<0.001) and PCT (AUC =0.647, P<0.001). Furthermore, the constructed predictive model of NLR + PCT + PRISM III showed a better prediction significance than they alone (AUC =0.888, P<0.001).
CONCLUSIONS: Results indicated that the initial NLR value was a significant biomarker for predicting severe pediatric sepsis. The combined NLR and PCT improved the evaluation for further early identification of severe sepsis in children. 2021 Translational Pediatrics. All rights reserved.

Entities:  

Keywords:  Critical care; hematology; neutrophil-to-lymphocyte ratio (NLR); pediatric sepsis

Year:  2021        PMID: 33880335      PMCID: PMC8041612          DOI: 10.21037/tp-21-47

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


Introduction

Pediatric severe sepsis and septic shock continue to be a leading cause of pediatric intensive care unit (PICU) admissions, and have shown to be related to significant pediatric mortality and healthcare costs (1,2). Alert and timely diagnosis and treatment continue to be recommended as the optimal method of choice for preventing severe pediatric sepsis and septic shock (3). Over the last decades, no single novel effective medical therapy or decisive diagnostic tool has been reported (3). Although the mortality of pediatric sepsis is declining, the burden of poor prognosis of severe sepsis in the pediatric population continues to be difficult to eliminate (4); therefore, the focus on this patient population should be intensified. Thus far, early the detection and treatment have been demonstrated to have the greatest effect in improving prognosis for pediatric severe sepsis patients. Numerous biomarkers have been evaluated to distinguish sepsis from non infectious causes of SIRS, although none have been entirely useful. Procalcitonin (PCT) is currently the most frequently used biomarker for sepsis and increases during systemic inflammatory response and sepsis, especially in systemic bacterial, parasitic and fungal infections. However, the PCT testing is expensive and takes a long time. Therefore, clinicians need to develop tools which are inexpensive, rapid and easy to measure. The neutrophils and the lymphocytes are the key cellular component of the human host defense system against an infection. During the course of sepsis, the number of white blood cells may vary, depending on the stage of sepsis, the patient’s immunologic status, and the etiology of the infection. Increased number of neutrophils and decreased number of lymphocytes alert the clinician for an infection. A higher NLR may indicate a severe inflammatory progression in the patient (5). Although a number of clinical biomarkers for sepsis have been extensively studied, few have been examined in pediatric sepsis, especially severe sepsis (6-9). As a biomarker, the predictive and prognostic value of NLR in pulmonary and cardiovascular disease, as well as cancer, has been indicated (10,11). There were many reports about the applications of neutrophil-to-lymphocyte ratio (NLR) as a predictive marker for adult sepsis, however, there was only one study about NLR for pediatric sepsis, and the included samples were few (12,13). We enrolled 202 children to assess whether initial NLR at PICU admission could effectively predict the incidence of severe sepsis in children. We present the following article in accordance with the STROBE reporting checklist (available at http://dx.doi.org/10.21037/tp-21-47).

Methods

Study subjects

This retrospective study recruited critically ill children with severe sepsis who were admitted to the PICU of the Department of Critical Care Medicine, West China Hospital of Sichuan University, from January 2019 to January 2020. The ethics committee of West China Hospital of Sichuan University approved this study (No. NCT03598127). All procedures performed in this study involving human participants were in accordance with the declaration of Helsinki (as revised in 2013). Individual consent for this retrospective analysis was waived.

Patient selection

Patients were eligible for inclusion based on the following criteria: (I) older than 60 days and younger than 18 years; (II) diagnosed as severe sepsis or septic shock during PICU hospitalization; (III) counts of lymphocyte and neutrophil determined at PICU admission. Meanwhile, the exclusion criteria were as follows: (I) younger than 60 days or older than 18 years; (II) missing data regarding lymphocyte and neutrophil at PICU admission; (III) missing covariate data for multiple-variable alterations; (IV) repeated admissions to the PICU. Patients satisfying the recruitment standards were enrolled in the study.

Definitions

Severe sepsis was defined according to the criteria established by the International Pediatric Sepsis Consensus Conference (14). Severe sepsis was considered present when the patient met one of the following criteria: (I) cardiovascular system dysfunction, (II) acute respiratory distress syndrome, (III) dysfunction of 2 or more other organs (cardiovascular, respiratory, neurologic, hematologic, renal, hepatic). Septic shock was defined as sepsis and cardiovascular organ dysfunction. In our study, we included septic shock in severe sepsis.

Data collection and outcomes

We collected the following data for all the patients within 24 hours of admission from the database at PICU: demographic information, source of infection, and laboratory tests. To estimate disease severity, Pediatric Risk of Mortality (PRISM III) score, a physiology-based predictor for risk of mortality, was calculated at the baseline within 24 hours of admission at the PICU (15). We collected laboratory findings, including white blood cell, neutrophil, lymphocyte, monocyte, and platelet counts; NLR and platelet-to-lymphocyte ratio (PLR); and albumin and PCT levels. The primary outcome was all-cause mortality 28 days after PICU arrival. Secondary clinical outcomes were hospital stay time, PICU stay time, and mechanical ventilation length.

Statistical analysis

SPSS version 22.0 (IBM Corp., USA) and MedCalc version 15.0 were used for statistical analyses. General distribution data are expressed as mean and SD, while binomial variables are expressed as median or interquartile range (IQR). Categorical variables were compared using the χ2 test. The variables of the severe sepsis and control groups were compared using the t-test or Mann-Whitney test. Univariate and subsequent multivariate logistic regression analyses were used to assess risk factors of severe pediatric sepsis. Area under the receiver operating characteristic curve (AUC) was used to evaluate the variables’ predictive performance. When a significant AUC was generated, the maximum possible sum of the sensitivity and specificity levels was considered to be the optimal cutoff point. A P value <0.05 indicated statistical significance.

Results

Baseline characteristics of the patient

During the study period, a total of 202 patients (severe sepsis 45, non-severe sepsis 157) were enrolled in the final analysis (). Among all 45 severe sepsis patients, 8 patients (17.78%) had septic shock. The median age was 13 months (IQR 3.00−78.00), and 115 (56.9%) patients were male. The median PRISM III score was 10 (IQR 6.00–15.00). The PRISM III score of severe pediatric sepsis was higher compared to the control group (P=0.002). Moreover, of the total patients, 17.8% had respiratory system infection, 41.1% had gastrointestinal system infection, 5.4% had central nervous system infection, 5.0% had bloodstream infection, and 12.9% had multiple infections. The number of multiple infections in the severe sepsis group was noticeably higher than that in the nonsevere sepsis group (P<0.001).
Figure 1

The flow chart of screening and enrollment. PICU, pediatric intensive care unit.

The flow chart of screening and enrollment. PICU, pediatric intensive care unit. In the laboratory tests, the median value of PCT was 2.21 (IQR 0.37–11.82) and NLR was 3.73 (IQR 2.04–6.59). The NLR and PCT levels were significantly higher in the severe sepsis group compared to the control group (P<0.001, P=0.003, respectively). Finally, the length of PICU stay time (P<0.001), hospital stay time (P<0.001), and mechanical ventilation time (P=0.004) in the severe sepsis group were longer than those in the control group, but no statistical significance was found in 28-day mortality (P=0.066). The baseline clinical and laboratory features of the patients are described in .
Table 1

Baseline characteristics

VariablesTotal (n=202)Control group (n=157)SS group (n=45)P value
Age, months13.00 (3.00, 78.00)12.00 (3.00, 57.50)58.00 (4.00, 113.5)0.022
Male, n (%)115 (56.9)88 (56.1)27 (60.0)0.637
Weight, kg9.00 (4.50, 20.00)8.40 (4.5, 17.00)16.00 (6.00, 17.00)0.014
Temperature, °C38.2 (37.5, 39.00)38.1 (37.5, 39.00)38.2 (37.50, 39.15)0.711
PRISM10.00 (6.00, 15.00)9.00 (6.00, 13.00)14.00 (7.50, 25.00)0.002
Source of infection
Respiratory system, n (%)36 (17.8)27 (17.2)9 (20)0.665
Gastrointestinal system, n (%)83 (41.1)69 (43.9)14 (31.1)0.123
Central nervous system, n (%)11 (5.4)9 (5.7)2 (4.4)0.737
Blood stream, n (%)10 (5.0)8 (5.1)2 (4.4)0.859
Multiple infection, n (%)26 (12.9)13 (8.3)13 (28.9)<0.001
Others, n (%)36 (17.8)31 (19.7)5 (11.1)0.182
Laboratory tests
White blood cell, 109/L12.25 (8.05, 16.76)11.64 (7.38, 15.94)14.64 (8.90, 18.23)0.078
Neutrophil, 109/L3.86 (1.89, 8.40)3.90 (1.94, 7.57)3.54 (1.50, 11.73)0.664
Lymphocyte, 109/L16.95 (2.29, 34.28)16.8 (2.54, 33.55)18.90 (1.35, 35.75)0.345
Monocyte, 109/L1.96 (0.76, 8.46)1.91 (0.76, 7.94)2.41 (0.715, 10.66)0.649
Platelet, 109/L250.5 (169.5, 362.25)262.0 (186.5, 362.5)206.0 (110.5, 328.5)0.049
NLR3.73 (2.04, 6.59)3.03 (1.71, 5.64)6.03 (3.74, 11.51)<0.001
PLR128.30 (67.38, 196.15)124.09 (69.41, 188.70)154.82 (62.26, 258.0)0.371
Albumin, g/dL2.23 (0.71, 33.73)2.81 (0.78, 34.45)1.29 (0.49, 33.4)0.159
PCT, ìg/L2.21 (0.37, 11.82)1.71 (0.34, 7.80)9.50 (0.64, 42.94)0.003
Clinical outcome
Length of PICU stay, days6.00 (3.60, 11.55)5.90 (3.60, 10.25)8.90 (3.78, 22.00)<0.001
Length of hospital stay, days16.00 (9.08, 27.50)15.00 (9.00, 22.35)23.50 (12.30, 41.80)<0.001
Mechanical ventilation time, hours19.00 (3.00, 86.50)13.50 (3.00, 52.5)50.00 (10.50, 203.0)0.004
28-day mortality, n (%)21 (10.4)13 (8.3)8 (17.8)0.066

All values are expressed as n (%) or median (first to third quartile). SS group, severe sepsis group; PRISM, Pediatric Risk of Mortality; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PCT, procalcitonin; PICU, pediatric intensive care unit.

All values are expressed as n (%) or median (first to third quartile). SS group, severe sepsis group; PRISM, Pediatric Risk of Mortality; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PCT, procalcitonin; PICU, pediatric intensive care unit.

Logistic regression analysis

Univariate logistic regression was conducted to determine the relationships of the respective variables with the incidence of severe sepsis. The results indicated that age (P=0.004), weight (P=0.012), multiple infections (P=0.001), NLR (P<0.001), PCT (P<0.001), and PRISM III (P<0.001) were risk factors of severe sepsis. In multivariate logistic regression analysis, multiple infections (P=0.013), NLR (P=0.006), PCT (P=0.025), and PRISM III (P<0.001) were associated with the incidence of severe sepsis. The results of univariate and multivariate logistic regression are shown in .
Table 2

Univariate analysis and multivariate logistic regression analysis of risk factors associated with pediatric severe sepsis

VariablesUnivariate analysisMultivariate analysis
OR (95% Cl)P valueOR (95% Cl)P value
Age1.008 (1.003, 1.014)0.0040.994 (0.974, 1.014)0.552
Male1.176 (0.599, 2.309)0.6370.716 (0.261, 1.967)0.517
Weight1.032 (1.007, 1.058)0.0121.035 (0.950, 1.128)0.43
Respiratory system1.204 (0.52, 2.788)0.6650.860 (0.157, 4.715)0.862
Gastrointestinal system0.576 (0.284, 1.166)0.1250.612 (0.129, 2.903)0.536
Central nervous system0.765 (0.159, 3.674)0.7380.449 (0.036, 5.607)0.534
Blood stream0.866 (0.177, 4.232)0.8592.672 (0.107, 66.699)0.549
Multiple infection4.50 (1.906, 10.623)0.0018.084 (1.559, 41.927)0.013
White blood cell1.049 (0.997, 1.104)0.0631.064 (0.882, 1.283)0.515
Neutrophil1.044 (0.989, 1.103)0.1190.959 (0.775, 1.186)0.699
Lymphocyte0.998 (0.978, 1.018)0.8610.967 (0.897, 1.043)0.386
Monocyte1.034 (0.975, 1.096)0.2650.881 (0.674, 1.153)0.357
Platelet0.999 (0.996, 1.001)0.2221.001 (0.997, 1.006)0.619
NLR1.143 (1.062, 1.230)<0.0011.259 (1.070, 1.481)0.006
PLR1.003 (1.000, 1.005)0.0360.997 (0.989, 1.004)0.392
Albumin0.994 (0.975, 1.013)0.5480.962 (0.896, 1.034)0.296
PCT1.022 (1.01, 1.034)<0.0011.018 (1.002, 1.035)0.025
Temperature1.077 (0.766, 1.514)0.6710.754 (0.439, 1.298)0.309
PRISM1.088 (1.046,1.133)<0.0011.154 (1.079, 1.236)<0.001

NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PCT, procalcitonin; PRISM, Pediatric Risk of Mortality; OR, odds ratio; CI, confidence interval.

NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PCT, procalcitonin; PRISM, Pediatric Risk of Mortality; OR, odds ratio; CI, confidence interval.

Predictive value of NLR

The AUC, cutoff value, sensitivity, specificity of PRISM III, PCT, and NLR for predicting severe sepsis are presented in . NLR had the highest predictive power for severe sepsis with an AUC of 0.715 and a cutoff value of 4.06; this was followed by PRISM III score (AUC =0.651, P<0.001) and PCT (AUC =0.647, P<0.001) ().
Table 3

Comparison of AUC values for predicting pediatric severe sepsis

VariablesAUCP value95% ClCutoff valueSensitivity (%)Specificity (%)
PRISM0.6510.0050.581–0.71613.0051.177.7
PCT0.6470.0040.576–0.71311.8648.983.00
NLR0.715<0.0010.647–0.7764.0675.5662.42
NLR + PCT0.795<0.0010.717–0.87273.374.50
Model0.888<0.0010.835–0.92891.1074.50

AUC, area under the receiver operating characteristic curve; PRISM, Pediatric Risk of Mortality; NLR, neutrophil-to-lymphocyte ratio; PCT, procalcitonin; CI, confidence interval.

Figure 2

ROC curve analysis comparing the predictive value of severe pediatric sepsis. ROC, receiver operating characteristic curve.

AUC, area under the receiver operating characteristic curve; PRISM, Pediatric Risk of Mortality; NLR, neutrophil-to-lymphocyte ratio; PCT, procalcitonin; CI, confidence interval. ROC curve analysis comparing the predictive value of severe pediatric sepsis. ROC, receiver operating characteristic curve.

Predictive value of the constructed model

We constructed a combined Receiver operating characteristic (ROC) curve model of NLR and PCT. The AUC of the NLR + PCT model was 0.795 (P<0.001), which was noticeably higher than that of the NLR-alone (Z=2.051, P=0.043) and PCT-alone (Z=3.108, P=0.002) models (). Furthermore, we made use of three statistically significant factors, including PRISM III, PCT, and NLR, to construct the predictive model. The predictive model of NLR+PCT+PRISM III exhibited an AUC of 0.888 (P<0.001). The sensitivities and specificities of the predictive model were 91.1% and 74.5%, respectively, which were noticeably higher than those of the NLR + PCT (Z=2.948, P=0.003) model (). The nomogram and calibration plot for NLR + PCT in predicting severe sepsis in pediatric patients are presented in .
Figure 3

NLR + PCT in predicting severe sepsis in pediatric patients. (A) Nomogram of the constructed predictive model for predicting severe sepsis in included pediatric patients. (B) Calibration plot of the constructed predictive model for predicting severe sepsis in included pediatric patients.

NLR + PCT in predicting severe sepsis in pediatric patients. (A) Nomogram of the constructed predictive model for predicting severe sepsis in included pediatric patients. (B) Calibration plot of the constructed predictive model for predicting severe sepsis in included pediatric patients.

Discussion

In this study, we found that the initial NLR obtained at PICU admission was a significant predictive biomarker for pediatric severe sepsis patients. Moreover, the predictive model of NLR + PCT + PRISM III demonstrated a greater prediction performance and could provide earlier detection of severe sepsis and better guide clinical practice. Our research placed a higher emphasis on assessing the incidence of severe sepsis in children, which might be the key to reducing mortality in the PICU. This study was the first to examine the relationship between NLR and severe pediatric sepsis in the PICU. Unlike sepsis, severe sepsis is more associated with the failure of multiple organs and includes cardiovascular, respiratory, neurologic, hematologic, renal, and hepatic dysfunction (14). Mortality for severe pediatric sepsis has been reported to be nearly 3 times higher than that for regular sepsis (16). Thus, severe sepsis is a key contributor to high ICU mortality in children, and our study has highlighted the need for the early detection of this condition. Before severe sepsis develops into septic shock, early identification of patients who may progress to severe sepsis and antibiotic treatment and efficient fluid resuscitation may reduce mortality (17-20). The causes of elevated NLR and poor prognosis in severe sepsis patients are unclear. One of the most convincing explanations is primarily based on the physiological link between systemic inflammation and stress (21-24). NLR is able to indicate the patient’s response to inflammation. The upregulation in the number of neutrophils may indicate the presence of an uncleared infected lesion which inhibits lymphocytes. Accumulating evidence has pointed to neutrophils as vital cellular components of the natural immune system’s defense against infection, with lymphocytes the being main cellular component of the adaptive immune system (25,26). Lymphocytes play an essential role in regulating inflammation, and the loss of lymphocytes attributed to apoptosis induced by persistent sepsis is likely to cause the suppression of the immune system (26). Therefore, neutropenia and lymphopenia resulting from the continuous suppression of the immune system may be the theoretical basis underlying the ability of NLR to predict severe sepsis. In the present study, the predictive significance of NLR, combined with PCT and PRISM III score, in pediatric severe sepsis patients in the PICU was comparatively assessed. NLR was revealed to have a significant predictive capacity to predict severe sepsis in comparison with PCT in pediatric patients. Furthermore, the constructed predictive model of NLR + PCT + PRISM III showed an even better prediction significance than that of each of these factors used alone. The PRISM III score (15) was assessed used 17 physiologic variables classified in the following fashion: (I) cardiovascular and nervous system (systolic blood pressure, heart rate, temperature, Glasgow coma scale, pupillary reactions); (II) blood gas (acidosis, CO2, pH, PaCO2, PaO2); (III) blood routine and biochemistry test (white blood cell count, platelet count, partial thromboplastin time). As can be seen in the variables above, there is little emphasis to no emphasis on inflammation, neutrophils, and lymphocytes in the blood routine for calculating the score. Therefore, the addition of NLR and PCT can enhance the capacity of the PRISM III scores to predict severe sepsis. Studies have shown that C-reactive protein (CRP) and PCT are good indicators for predicting sepsis in children (6). However, under various inflammatory conditions, CRP and PCT levels can also be elevated, so there is limited value in identifying infection from other causes of inflammation. Furthermore, the cost of PCT and CRP testing is relatively higher than that of NLR, especially CRP. Since there is no apparent inflammatory reaction in the early sepsis stage, PCT and CRP are not used as routine testing items. Thus, NLR also possesses the advantage of being more economical for early prediction. This study has a few limitations that should be considered. First, our study was limited by its retrospective design. Second, because our hospital did not routinely detect CRP values, the authors could not compare the predictive ability of NLR and CRP. We hope that further research will focus on this aspect. Third, the number of patients enrolled in the study was small, and prospective analyses based on larger sample sizes are required for in-depth verification.

Conclusions

Among NLR, PRISM III, and PCT, the initial NLR value at PICU admission was the most useful biomarker for predication of severe sepsis in pediatric patients. The constructed predictive model of NLR + PCT + PRISM III was a highly sensitive and specific predictive model for severe sepsis, demonstrating great potential for greater prediction accuracy of severe sepsis in children. The article’s supplementary files as
  26 in total

1.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

Authors:  R Zahorec
Journal:  Bratisl Lek Listy       Date:  2001       Impact factor: 1.278

2.  Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.

Authors:  Scott L Weiss; Julie C Fitzgerald; John Pappachan; Derek Wheeler; Juan C Jaramillo-Bustamante; Asma Salloo; Sunit C Singhi; Simon Erickson; Jason A Roy; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

Review 3.  Cytokine storm and sepsis disease pathogenesis.

Authors:  Benjamin G Chousterman; Filip K Swirski; Georg F Weber
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

Review 4.  International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Authors:  Brahm Goldstein; Brett Giroir; Adrienne Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

Review 5.  Precision medicine in pediatric sepsis.

Authors:  Mihir R Atreya; Hector R Wong
Journal:  Curr Opin Pediatr       Date:  2019-06       Impact factor: 2.856

Review 6.  The immune system's role in sepsis progression, resolution, and long-term outcome.

Authors:  Matthew J Delano; Peter A Ward
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

7.  Treatment of Pediatric Septic Shock With the Surviving Sepsis Campaign Guidelines and PICU Patient Outcomes.

Authors:  Jennifer K Workman; Stefanie G Ames; Ron W Reeder; E Kent Korgenski; Susan M Masotti; Susan L Bratton; Gitte Y Larsen
Journal:  Pediatr Crit Care Med       Date:  2016-10       Impact factor: 3.624

Review 8.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Mairéad G McNamara; Boštjan Šeruga; Francisco E Vera-Badillo; Priya Aneja; Alberto Ocaña; Raya Leibowitz-Amit; Guru Sonpavde; Jennifer J Knox; Ben Tran; Ian F Tannock; Eitan Amir
Journal:  J Natl Cancer Inst       Date:  2014-05-29       Impact factor: 13.506

9.  Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern.

Authors:  Daithi S Heffernan; Sean F Monaghan; Rajan K Thakkar; Jason T Machan; William G Cioffi; Alfred Ayala
Journal:  Crit Care       Date:  2012-01-20       Impact factor: 9.097

10.  Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children.

Authors:  Fatih Aygün; Fatih Varol; Cansu Durak; Mey Talip Petmezci; Alper Kacar; Hasan Dursun; Ahmet Irdem; Haluk Çokuğraş; Yıldız Camcıoğlu; Halit Çam
Journal:  Medicina (Kaunas)       Date:  2019-07-07       Impact factor: 2.430

View more
  6 in total

1.  Impact on the survival of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and monocyte-lymphocyte ratio on prognosis in children with Hodgkin lymphoma.

Authors:  Kubra Ertan; Aysenur Dogru; Buket Kara; Yavuz Koksal
Journal:  Saudi Med J       Date:  2022-05       Impact factor: 1.422

2.  Value of the Neutrophil-Lymphocyte Ratio in Predicting COVID-19 Severity: A Meta-analysis.

Authors:  Ying Wang; Jingyi Zhao; Lan Yang; Junhui Hu; Yinhui Yao
Journal:  Dis Markers       Date:  2021-10-08       Impact factor: 3.434

3.  Value of CRP, PCT, and NLR in Prediction of Severity and Prognosis of Patients With Bloodstream Infections and Sepsis.

Authors:  Peipei Liang; Feng Yu
Journal:  Front Surg       Date:  2022-03-07

4.  Predictive Value of Procalcitonin and Neutrophil-to-Lymphocyte Ratio Variations for Bloodstream Infection with Septic Shock.

Authors:  Peipei Liang; Feng Yu
Journal:  Med Sci Monit       Date:  2022-05-05

5.  Prognostic value of neutrophils to lymphocytes and platelets ratio for 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study.

Authors:  Shiyu Nie; Hongjin Wang; Qiuyu Liu; Ze Tang; Wu Tao; Nian Wang
Journal:  BMC Pulm Med       Date:  2022-08-15       Impact factor: 3.320

Review 6.  Neutrophil-Lymphocyte Ratio Predicting Case Severity in SARS-CoV-2 Infection: A Review.

Authors:  Sonal Agarwal
Journal:  Cureus       Date:  2022-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.